Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ZimVie Inc. - Common Stock (NQ:ZIMV)

18.77 +0.04 (+0.21%)
Streaming Delayed Price Updated: 1:30 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ZimVie Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
A Preview Of ZimVie's Earnings
Via Benzinga
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
Newest implant innovation is designed for immediacy and peri-implant health 
From ZimVie Inc.
Via GlobeNewswire
Fear & Greed Index Moves To 'Extreme Greed' Zone; S&P 500 Settles Higher
The CNN Money Fear and Greed index showed some easing in overall market sentiment, but the index moved to the "Extreme Greed" zone on Monday. The S&P 500 closed higher on Monday after recording gains... 
Via Benzinga
Topics Stocks
Barclays Maintains Underweight Rating for ZimVie: Here's What You Need To Know
Via Benzinga
ZimVie (ZIMV) Q2 2023 Earnings Call Transcript
ZIMV earnings call for the period ending June 30, 2023. 
Via The Motley Fool
ZimVie's Earnings Outlook
Via Benzinga
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07.... 
Via Benzinga
Topics Stocks
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Rises 3%; US Housing Market Index Increases In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500... 
Via Benzinga
Topics Stocks
ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday. 
Via Benzinga
Topics Stocks
Why Surgical And Medical Instrument Manufacturing Company ZimVie Shares Are Rocketing Today
ZimVie Inc (NASDAQ: ZIMV) shares are trading higher by over 33% after the company disclosed an agreement to sell its spine business to  
Via Benzinga
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
From ZimVie Inc.
Via GlobeNewswire
ZimVie (ZIMV) Q3 2023 Earnings Call Transcript
ZIMV earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
From ZimVie Inc.
Via GlobeNewswire
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
From ZimVie Inc.
Via GlobeNewswire
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles
Although few really enjoy talking about the subject, targeting stocks to sell is just as important for success as acquiring good ideas. 
Via InvestorPlace
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio 
From ZimVie Inc.
Via GlobeNewswire
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
From ZimVie Inc.
Via GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
Smaller height implants in all Mobi-C footprints to address patient anatomy 
From ZimVie Inc.
Via GlobeNewswire
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
From ZimVie Inc.
Via GlobeNewswire
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million. 
Via Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.